Share Price and Basic Stock Data
Last Updated: March 10, 2025, 11:32 am
| PEG Ratio | 1.45 |
|---|
Competitors of Zydus Wellness Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mishtann Foods Ltd | 603 Cr. | 5.60 | 21.8/4.75 | 1.75 | 7.38 | 0.02 % | 88.7 % | 98.7 % | 1.00 |
| Mrs Bectors Food Specialities Ltd | 8,536 Cr. | 1,382 | 2,200/964 | 59.9 | 182 | 0.24 % | 25.4 % | 23.2 % | 10.0 |
| Nakoda Group of Industries Ltd | 50.9 Cr. | 36.5 | 54.4/33.3 | 11.8 | 0.00 % | 1.80 % | 12.1 % | 10.0 | |
| ICL Organic Dairy Products Ltd | 23.8 Cr. | 39.7 | / | 1,192 | 20.1 | 0.00 % | 0.25 % | 0.17 % | 10.0 |
| Himalaya Food International Ltd | 69.6 Cr. | 12.0 | 28.4/11.6 | 14.3 | 24.4 | 0.00 % | 3.63 % | 3.61 % | 10.0 |
| Industry Average | 18,532.43 Cr | 750.62 | 163.19 | 119.30 | 0.24% | 20.85% | 21.11% | 6.56 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 388.09 | 639.78 | 696.40 | 429.10 | 416.40 | 713.00 | 702.10 | 439.90 | 403.20 | 782.60 | 841.00 | 492.90 | 461.90 |
| Expenses | 355.80 | 498.28 | 548.30 | 412.90 | 388.10 | 568.40 | 585.60 | 423.10 | 390.50 | 620.40 | 685.70 | 473.30 | 447.10 |
| Operating Profit | 32.29 | 141.50 | 148.10 | 16.20 | 28.30 | 144.60 | 116.50 | 16.80 | 12.70 | 162.20 | 155.30 | 19.60 | 14.80 |
| OPM % | 8.32% | 22.12% | 21.27% | 3.78% | 6.80% | 20.28% | 16.59% | 3.82% | 3.15% | 20.73% | 18.47% | 3.98% | 3.20% |
| Other Income | 2.69 | 1.96 | -0.90 | 1.40 | 0.80 | -6.50 | -11.80 | 4.10 | 3.40 | 4.00 | 5.00 | 9.90 | 3.80 |
| Interest | 6.42 | 5.98 | 4.10 | 3.00 | 3.80 | 5.20 | 5.10 | 6.50 | 6.30 | 6.10 | 3.60 | 0.90 | 3.30 |
| Depreciation | 5.84 | 6.08 | 6.10 | 6.40 | 5.90 | 6.60 | 6.20 | 5.80 | 6.10 | 5.70 | 5.10 | 4.90 | 5.20 |
| Profit before tax | 22.72 | 131.40 | 137.00 | 8.20 | 19.40 | 126.30 | 93.40 | 8.60 | 3.70 | 154.40 | 151.60 | 23.70 | 10.10 |
| Tax % | -2.55% | -1.45% | 0.00% | -3.66% | -1.03% | -15.04% | -18.20% | 31.40% | 91.89% | 2.66% | 2.57% | 11.81% | 36.63% |
| Net Profit | 23.30 | 133.30 | 137.00 | 8.50 | 19.60 | 145.30 | 110.40 | 5.90 | 0.30 | 150.30 | 147.70 | 20.90 | 6.40 |
| EPS in Rs | 3.66 | 20.95 | 21.53 | 1.34 | 3.08 | 22.83 | 17.35 | 0.93 | 0.05 | 23.62 | 23.21 | 3.28 | 1.01 |
Last Updated: March 3, 2025, 5:50 pm
Below is a detailed analysis of the quarterly data for Zydus Wellness Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹461.90 Cr.. The value appears to be declining and may need further review. It has decreased from 492.90 Cr. (Sep 2024) to ₹461.90 Cr., marking a decrease of 31.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹447.10 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 473.30 Cr. (Sep 2024) to ₹447.10 Cr., marking a decrease of 26.20 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹14.80 Cr.. The value appears to be declining and may need further review. It has decreased from 19.60 Cr. (Sep 2024) to ₹14.80 Cr., marking a decrease of 4.80 Cr..
- For OPM %, as of Dec 2024, the value is 3.20%. The value appears to be declining and may need further review. It has decreased from 3.98% (Sep 2024) to 3.20%, marking a decrease of 0.78%.
- For Other Income, as of Dec 2024, the value is ₹3.80 Cr.. The value appears to be declining and may need further review. It has decreased from 9.90 Cr. (Sep 2024) to ₹3.80 Cr., marking a decrease of 6.10 Cr..
- For Interest, as of Dec 2024, the value is ₹3.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.90 Cr. (Sep 2024) to ₹3.30 Cr., marking an increase of ₹2.40 Cr..
- For Depreciation, as of Dec 2024, the value is ₹5.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.90 Cr. (Sep 2024) to ₹5.20 Cr., marking an increase of ₹0.30 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹10.10 Cr.. The value appears to be declining and may need further review. It has decreased from 23.70 Cr. (Sep 2024) to ₹10.10 Cr., marking a decrease of 13.60 Cr..
- For Tax %, as of Dec 2024, the value is 36.63%. The value appears to be increasing, which may not be favorable. It has increased from 11.81% (Sep 2024) to 36.63%, marking an increase of 24.82%.
- For Net Profit, as of Dec 2024, the value is ₹6.40 Cr.. The value appears to be declining and may need further review. It has decreased from 20.90 Cr. (Sep 2024) to ₹6.40 Cr., marking a decrease of 14.50 Cr..
- For EPS in Rs, as of Dec 2024, the value is 1.01. The value appears to be declining and may need further review. It has decreased from ₹3.28 (Sep 2024) to 1.01, marking a decrease of ₹2.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:26 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 388 | 404 | 431 | 397 | 431 | 513 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,578 |
| Expenses | 291 | 319 | 331 | 305 | 331 | 387 | 658 | 1,446 | 1,522 | 1,664 | 1,918 | 2,020 | 2,226 |
| Operating Profit | 97 | 85 | 100 | 91 | 99 | 125 | 185 | 321 | 344 | 345 | 337 | 308 | 352 |
| OPM % | 25% | 21% | 23% | 23% | 23% | 24% | 22% | 18% | 18% | 17% | 15% | 13% | 14% |
| Other Income | 16 | 19 | 28 | 32 | 32 | 35 | 28 | -33 | -123 | 10 | -5 | -0 | 23 |
| Interest | 0 | 0 | 0 | 0 | 1 | 2 | 30 | 140 | 84 | 26 | 16 | 24 | 14 |
| Depreciation | 4 | 0 | 8 | 7 | 7 | 9 | 13 | 26 | 25 | 24 | 25 | 24 | 21 |
| Profit before tax | 108 | 104 | 120 | 117 | 124 | 150 | 171 | 121 | 112 | 306 | 291 | 260 | 340 |
| Tax % | 8% | 5% | 7% | 10% | 10% | 9% | -0% | -17% | -6% | -1% | -7% | -3% | |
| Net Profit | 99 | 98 | 111 | 105 | 111 | 137 | 171 | 142 | 119 | 309 | 310 | 267 | 325 |
| EPS in Rs | 24.85 | 24.69 | 27.88 | 26.43 | 27.89 | 34.27 | 29.33 | 24.58 | 18.66 | 48.54 | 48.78 | 41.94 | 51.12 |
| Dividend Payout % | 24% | 24% | 22% | 25% | 23% | 23% | 17% | 20% | 27% | 10% | 10% | 12% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -1.01% | 13.27% | -5.41% | 5.71% | 23.42% | 24.82% | -16.96% | -16.20% | 159.66% | 0.32% | -13.87% |
| Change in YoY Net Profit Growth (%) | 0.00% | 14.28% | -18.67% | 11.12% | 17.71% | 1.39% | -41.78% | 0.76% | 175.86% | -159.34% | -14.19% |
Zydus Wellness Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 23% |
| 3 Years: | 8% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 4% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 6% |
| Last Year: | 5% |
Last Updated: Unknown
Balance Sheet
Last Updated: February 12, 2025, 4:15 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 |
| Reserves | 217 | 286 | 367 | 439 | 518 | 652 | 3,329 | 3,403 | 4,504 | 4,780 | 5,059 | 5,294 | 5,431 |
| Borrowings | -0 | -0 | -0 | -0 | 25 | 25 | 1,569 | 1,519 | 550 | 387 | 297 | 329 | 154 |
| Other Liabilities | 93 | 99 | 102 | 89 | 100 | 112 | 503 | 610 | 548 | 461 | 413 | 462 | 359 |
| Total Liabilities | 349 | 425 | 508 | 568 | 682 | 829 | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,008 |
| Fixed Assets | 94 | 95 | 84 | 82 | 103 | 104 | 4,567 | 4,674 | 4,667 | 4,710 | 4,732 | 4,708 | 4,703 |
| CWIP | -0 | 0 | 0 | 0 | 0 | 0 | 10 | 4 | 4 | 12 | 13 | 10 | 17 |
| Investments | -0 | 5 | -0 | 94 | 30 | 148 | 46 | 110 | -0 | 27 | 70 | 78 | 367 |
| Other Assets | 255 | 324 | 423 | 391 | 550 | 577 | 835 | 802 | 995 | 943 | 1,018 | 1,354 | 921 |
| Total Assets | 349 | 425 | 508 | 568 | 682 | 829 | 5,459 | 5,590 | 5,666 | 5,692 | 5,833 | 6,148 | 6,008 |
Below is a detailed analysis of the balance sheet data for Zydus Wellness Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹64.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹5,431.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5,294.00 Cr. (Mar 2024) to ₹5,431.00 Cr., marking an increase of 137.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹154.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹329.00 Cr. (Mar 2024) to ₹154.00 Cr., marking a decrease of 175.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹359.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹462.00 Cr. (Mar 2024) to ₹359.00 Cr., marking a decrease of 103.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹6,008.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹6,148.00 Cr. (Mar 2024) to ₹6,008.00 Cr., marking a decrease of 140.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹4,703.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹4,708.00 Cr. (Mar 2024) to ₹4,703.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹17.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹10.00 Cr. (Mar 2024) to ₹17.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Sep 2024, the value is ₹367.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹78.00 Cr. (Mar 2024) to ₹367.00 Cr., marking an increase of 289.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹921.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,354.00 Cr. (Mar 2024) to ₹921.00 Cr., marking a decrease of 433.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹6,008.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹6,148.00 Cr. (Mar 2024) to ₹6,008.00 Cr., marking a decrease of 140.00 Cr..
Notably, the Reserves (₹5,431.00 Cr.) exceed the Borrowings (154.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 97.00 | 85.00 | 100.00 | 91.00 | 74.00 | 100.00 | 184.00 | 320.00 | -206.00 | -42.00 | 40.00 | -21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 2 | 1 | 3 | 3 | 6 | 42 | 24 | 18 | 26 | 34 | 44 |
| Inventory Days | 120 | 108 | 76 | 73 | 127 | 113 | 393 | 168 | 158 | 135 | 146 | 150 |
| Days Payable | 136 | 191 | 146 | 191 | 264 | 254 | 662 | 289 | 189 | 136 | 100 | 116 |
| Cash Conversion Cycle | -14 | -82 | -69 | -116 | -134 | -135 | -227 | -97 | -13 | 25 | 80 | 78 |
| Working Capital Days | -32 | -48 | -37 | -38 | -36 | -8 | 4 | -3 | 12 | 31 | 65 | 71 |
| ROCE % | 48% | 35% | 32% | 26% | 23% | 22% | 7% | 6% | 6% | 6% | 6% | 5% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 2,221,106 | 0.78 | 358.7 | 843,482 | 2025-03-10 | 163.33% |
| SBI Small Cap Fund | 1,034,243 | 0.67 | 167.03 | 843,482 | 2025-03-10 | 22.62% |
| ICICI Prudential Value Discovery Fund | 843,482 | 0.35 | 136.22 | 843,482 | 2025-03-10 | 0% |
| ICICI Prudential Multicap Fund | 243,627 | 0.37 | 39.34 | 843,482 | 2025-03-10 | -71.12% |
| Tata India Consumer Fund | 229,000 | 2.01 | 36.98 | 843,482 | 2025-03-10 | -72.85% |
| Aditya Birla Sun Life India GenNext Fund | 156,780 | 0.55 | 25.32 | 843,482 | 2025-03-10 | -81.41% |
| Tata Flexi Cap Fund | 140,000 | 0.85 | 22.61 | 843,482 | 2025-03-10 | -83.4% |
| ICICI Prudential Bharat Consumption Fund | 117,165 | 0.86 | 18.92 | 843,482 | 2025-03-10 | -86.11% |
| ICICI Prudential FMCG Fund - Dividend | 88,783 | 0.96 | 14.34 | 843,482 | 2025-03-10 | -89.47% |
| ICICI Prudential FMCG Fund - Growth | 88,783 | 0.96 | 14.34 | 843,482 | 2025-03-10 | -89.47% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 41.94 | 48.78 | 48.54 | 19.55 | 24.58 |
| Diluted EPS (Rs.) | 41.94 | 48.78 | 48.54 | 19.55 | 24.58 |
| Cash EPS (Rs.) | 45.71 | 52.71 | 52.25 | 22.61 | 29.16 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 842.37 | 805.07 | 761.28 | 717.87 | 600.18 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 842.37 | 805.07 | 761.28 | 717.87 | 600.18 |
| Revenue From Operations / Share (Rs.) | 366.01 | 354.36 | 315.75 | 293.36 | 306.42 |
| PBDIT / Share (Rs.) | 50.64 | 53.75 | 55.81 | 55.52 | 57.54 |
| PBIT / Share (Rs.) | 46.90 | 49.82 | 52.10 | 51.57 | 52.96 |
| PBT / Share (Rs.) | 40.90 | 45.71 | 48.09 | 17.63 | 21.03 |
| Net Profit / Share (Rs.) | 41.97 | 48.78 | 48.54 | 18.66 | 24.58 |
| NP After MI And SOA / Share (Rs.) | 41.97 | 48.78 | 48.54 | 18.66 | 24.58 |
| PBDIT Margin (%) | 13.83 | 15.16 | 17.67 | 18.92 | 18.77 |
| PBIT Margin (%) | 12.81 | 14.05 | 16.50 | 17.57 | 17.28 |
| PBT Margin (%) | 11.17 | 12.89 | 15.23 | 6.01 | 6.86 |
| Net Profit Margin (%) | 11.46 | 13.76 | 15.37 | 6.36 | 8.02 |
| NP After MI And SOA Margin (%) | 11.46 | 13.76 | 15.37 | 6.36 | 8.02 |
| Return on Networth / Equity (%) | 4.98 | 6.05 | 6.37 | 2.59 | 4.09 |
| Return on Capital Employeed (%) | 5.54 | 6.16 | 6.73 | 6.70 | 6.13 |
| Return On Assets (%) | 4.34 | 5.32 | 5.42 | 2.09 | 2.53 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.06 | 0.43 |
| Total Debt / Equity (X) | 0.06 | 0.05 | 0.07 | 0.12 | 0.43 |
| Asset Turnover Ratio (%) | 0.38 | 0.05 | 0.04 | 0.02 | 0.02 |
| Current Ratio (X) | 1.62 | 1.31 | 1.06 | 1.10 | 1.26 |
| Quick Ratio (X) | 1.02 | 0.65 | 0.58 | 0.62 | 0.78 |
| Inventory Turnover Ratio (X) | 2.24 | 0.89 | 0.78 | 0.54 | 0.80 |
| Dividend Payout Ratio (NP) (%) | 11.91 | 10.25 | 10.30 | 0.00 | 40.69 |
| Dividend Payout Ratio (CP) (%) | 10.93 | 9.48 | 9.57 | 0.00 | 34.30 |
| Earning Retention Ratio (%) | 88.09 | 89.75 | 89.70 | 0.00 | 59.31 |
| Cash Earning Retention Ratio (%) | 89.07 | 90.52 | 90.43 | 0.00 | 65.70 |
| Interest Coverage Ratio (X) | 13.42 | 21.27 | 13.92 | 4.22 | 2.37 |
| Interest Coverage Ratio (Post Tax) (X) | 12.71 | 20.93 | 13.11 | 3.99 | 2.33 |
| Enterprise Value (Cr.) | 9439.42 | 10116.33 | 9760.97 | 12849.96 | 8915.13 |
| EV / Net Operating Revenue (X) | 4.05 | 4.49 | 4.86 | 6.88 | 5.05 |
| EV / EBITDA (X) | 29.31 | 29.58 | 27.48 | 36.37 | 26.87 |
| MarketCap / Net Operating Revenue (X) | 4.02 | 4.37 | 4.75 | 6.72 | 4.23 |
| Retention Ratios (%) | 88.08 | 89.74 | 89.69 | 0.00 | 59.30 |
| Price / BV (X) | 1.75 | 1.93 | 1.97 | 2.75 | 2.16 |
| Price / Net Operating Revenue (X) | 4.02 | 4.37 | 4.75 | 6.72 | 4.23 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 |
After reviewing the key financial ratios for Zydus Wellness Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 41.94. This value is within the healthy range. It has decreased from 48.78 (Mar 23) to 41.94, marking a decrease of 6.84.
- For Diluted EPS (Rs.), as of Mar 24, the value is 41.94. This value is within the healthy range. It has decreased from 48.78 (Mar 23) to 41.94, marking a decrease of 6.84.
- For Cash EPS (Rs.), as of Mar 24, the value is 45.71. This value is within the healthy range. It has decreased from 52.71 (Mar 23) to 45.71, marking a decrease of 7.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 842.37. It has increased from 805.07 (Mar 23) to 842.37, marking an increase of 37.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 842.37. It has increased from 805.07 (Mar 23) to 842.37, marking an increase of 37.30.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 366.01. It has increased from 354.36 (Mar 23) to 366.01, marking an increase of 11.65.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 50.64. This value is within the healthy range. It has decreased from 53.75 (Mar 23) to 50.64, marking a decrease of 3.11.
- For PBIT / Share (Rs.), as of Mar 24, the value is 46.90. This value is within the healthy range. It has decreased from 49.82 (Mar 23) to 46.90, marking a decrease of 2.92.
- For PBT / Share (Rs.), as of Mar 24, the value is 40.90. This value is within the healthy range. It has decreased from 45.71 (Mar 23) to 40.90, marking a decrease of 4.81.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 41.97. This value is within the healthy range. It has decreased from 48.78 (Mar 23) to 41.97, marking a decrease of 6.81.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 41.97. This value is within the healthy range. It has decreased from 48.78 (Mar 23) to 41.97, marking a decrease of 6.81.
- For PBDIT Margin (%), as of Mar 24, the value is 13.83. This value is within the healthy range. It has decreased from 15.16 (Mar 23) to 13.83, marking a decrease of 1.33.
- For PBIT Margin (%), as of Mar 24, the value is 12.81. This value is within the healthy range. It has decreased from 14.05 (Mar 23) to 12.81, marking a decrease of 1.24.
- For PBT Margin (%), as of Mar 24, the value is 11.17. This value is within the healthy range. It has decreased from 12.89 (Mar 23) to 11.17, marking a decrease of 1.72.
- For Net Profit Margin (%), as of Mar 24, the value is 11.46. This value exceeds the healthy maximum of 10. It has decreased from 13.76 (Mar 23) to 11.46, marking a decrease of 2.30.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 11.46. This value is within the healthy range. It has decreased from 13.76 (Mar 23) to 11.46, marking a decrease of 2.30.
- For Return on Networth / Equity (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 15. It has decreased from 6.05 (Mar 23) to 4.98, marking a decrease of 1.07.
- For Return on Capital Employeed (%), as of Mar 24, the value is 5.54. This value is below the healthy minimum of 10. It has decreased from 6.16 (Mar 23) to 5.54, marking a decrease of 0.62.
- For Return On Assets (%), as of Mar 24, the value is 4.34. This value is below the healthy minimum of 5. It has decreased from 5.32 (Mar 23) to 4.34, marking a decrease of 0.98.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.06. This value is within the healthy range. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.38. It has increased from 0.05 (Mar 23) to 0.38, marking an increase of 0.33.
- For Current Ratio (X), as of Mar 24, the value is 1.62. This value is within the healthy range. It has increased from 1.31 (Mar 23) to 1.62, marking an increase of 0.31.
- For Quick Ratio (X), as of Mar 24, the value is 1.02. This value is within the healthy range. It has increased from 0.65 (Mar 23) to 1.02, marking an increase of 0.37.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.24. This value is below the healthy minimum of 4. It has increased from 0.89 (Mar 23) to 2.24, marking an increase of 1.35.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 11.91. This value is below the healthy minimum of 20. It has increased from 10.25 (Mar 23) to 11.91, marking an increase of 1.66.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.93. This value is below the healthy minimum of 20. It has increased from 9.48 (Mar 23) to 10.93, marking an increase of 1.45.
- For Earning Retention Ratio (%), as of Mar 24, the value is 88.09. This value exceeds the healthy maximum of 70. It has decreased from 89.75 (Mar 23) to 88.09, marking a decrease of 1.66.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.07. This value exceeds the healthy maximum of 70. It has decreased from 90.52 (Mar 23) to 89.07, marking a decrease of 1.45.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 13.42. This value is within the healthy range. It has decreased from 21.27 (Mar 23) to 13.42, marking a decrease of 7.85.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 12.71. This value is within the healthy range. It has decreased from 20.93 (Mar 23) to 12.71, marking a decrease of 8.22.
- For Enterprise Value (Cr.), as of Mar 24, the value is 9,439.42. It has decreased from 10,116.33 (Mar 23) to 9,439.42, marking a decrease of 676.91.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.05. This value exceeds the healthy maximum of 3. It has decreased from 4.49 (Mar 23) to 4.05, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 24, the value is 29.31. This value exceeds the healthy maximum of 15. It has decreased from 29.58 (Mar 23) to 29.31, marking a decrease of 0.27.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.02. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 23) to 4.02, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 24, the value is 88.08. This value exceeds the healthy maximum of 70. It has decreased from 89.74 (Mar 23) to 88.08, marking a decrease of 1.66.
- For Price / BV (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has decreased from 1.93 (Mar 23) to 1.75, marking a decrease of 0.18.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.02. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 23) to 4.02, marking a decrease of 0.35.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zydus Wellness Ltd:
- Net Profit Margin: 11.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.54% (Industry Average ROCE: 20.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.98% (Industry Average ROE: 21.11%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.02
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.3 (Industry average Stock P/E: 163.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.46%
About the Company - Qualitative Analysis
No data availabale for About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industry not found | Address not found | Contact not found |
Management Data not Available
FAQ
What is the latest intrinsic value of Zydus Wellness Ltd?
The latest intrinsic value of Zydus Wellness Ltd as on 11 March 2025 is ₹1190.03, which is 26.81% lower than the current market price of 1,626.00, indicating the stock is overvalued by 26.81%. The intrinsic value of Zydus Wellness Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹10,347 Cr. and recorded a high/low of ₹2,484/1,440 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹5,431 Cr and total liabilities of ₹6,008 Cr.
What is the Market Cap of Zydus Wellness Ltd?
The Market Cap of Zydus Wellness Ltd is 10,347 Cr..
What is the current Stock Price of Zydus Wellness Ltd as on 11 March 2025?
The current stock price of Zydus Wellness Ltd as on 11 March 2025 is ₹1,626.
What is the High / Low of Zydus Wellness Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Zydus Wellness Ltd stocks is ₹2,484/1,440.
What is the Stock P/E of Zydus Wellness Ltd?
The Stock P/E of Zydus Wellness Ltd is 32.3.
What is the Book Value of Zydus Wellness Ltd?
The Book Value of Zydus Wellness Ltd is 863.
What is the Dividend Yield of Zydus Wellness Ltd?
The Dividend Yield of Zydus Wellness Ltd is 0.31 %.
What is the ROCE of Zydus Wellness Ltd?
The ROCE of Zydus Wellness Ltd is 5.33 %.
What is the ROE of Zydus Wellness Ltd?
The ROE of Zydus Wellness Ltd is 5.32 %.
What is the Face Value of Zydus Wellness Ltd?
The Face Value of Zydus Wellness Ltd is 10.0.